Kline v. Elite Medical Laboratories, Inc.

CourtDistrict Court, M.D. Pennsylvania
DecidedDecember 13, 2019
Docket1:19-cv-01043
StatusUnknown

This text of Kline v. Elite Medical Laboratories, Inc. (Kline v. Elite Medical Laboratories, Inc.) is published on Counsel Stack Legal Research, covering District Court, M.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Kline v. Elite Medical Laboratories, Inc., (M.D. Pa. 2019).

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF PENNSYLVANIA

ROBERT D. KLINE, ) CIVIL ACTION NO. 1:19-CV-1043 Plaintiff ) ) v. ) ) (ARBUCKLE, M.J.) ELITE MEDICAL LABORATORIES, ) INC., et al., ) Defendants ) MEMORANDUM OPINION Defendant Dr. Richard Arriviello’s Motion to Dismiss (Doc. 15) On April 9, 2019, Richard Kline (“Plaintiff”) filed a pro se Praecipe to Issue Writ of Summons in the Mifflin County Court of Common Pleas. (Doc. 1, ¶ 1). On May 31, 2019, Plaintiff filed a Complaint in then Mifflin County Court of Common Pleas in which he alleged that the following Defendants violated the Telephone Consumer Protection Act (“TCPA”), 47 U.S.C. § 227 et seq. and the regulations promulgated thereunder: (1) Elite Medical Laboratories, Inc.; (2) Performance Laboratories, LLC; and, (3) Dr. Richard Arriviello, Jr. (Doc. 1, pp. 10-14). On June 6, 2019, this case was removed from the Court of Common Pleas of Mifflin County to the United States District Court for the Middle District of Pennsylvania by Richard Arriviello (“Defendant Arriviello”). (Doc. 1). Since its removal to federal court, Plaintiff has filed an Amended Complaint (Doc. 12)— currently the operative complaint in this case—and has stipulated to the dismissal

of all claims against two of the Defendants (Doc. 17). Defendant Arriviello is the only remaining Defendant in this case. The parties have consented to proceed before a United States Magistrate Judge. (Doc. 21).

Presently pending before the Court is Defendant Arriviello’s Motion to Dismiss Plaintiff’s Amended Complaint. (Doc. 15). Along with his Motion, Defendant Arriviello filed a brief in support. (Doc. 18). On August 28, 2019, Plaintiff filed a brief in opposition. (Doc. 20). This Motion is ripe for decision.

Upon consideration of Defendant Arriviello’s Motion, IT IS ORDERED THAT it be GRANTED and that Plaintiff’s claims against Defendant Arriviello be DISMISSED.

I. BACKGROUND AND PROCEDURAL HISTORY During March and April of 2019, Plaintiff received the first of numerous calls that he alleges were made without his consent to his personal cellular telephone number, using an automatic telephone dialing system (“ATDS”), or

robocall1 equipment. (Doc. 12, ¶¶ 16). During these calls, the callers identified themselves as either “Medicare Department” or “Cancer Screening Center.” (Doc.

1 A robocall is a phone call that uses a computerized autodialer to deliver a message. Robocalls can be personalized audio messages that simulate an actual personal phone call. 12, ¶¶ 16, 19). During the first few calls, Plaintiff asked the callers to stop and told them that he was on the national “do not call list.” (Doc. 12, ¶ 16). The calls

continued despite Plaintiff’s request that the callers stop. (Doc. 12, ¶ 20). Because the calls did not stop, Plaintiff attempted to gain further information from the callers, presumably so he could take legal action to get the calls to stop.

(Doc. 12, ¶ 20). During the calls, the callers asked questions relating to Plaintiff’s family cancer history and told Plaintiff that their “doctor will review these answers and he will make a diagnosis. You will be mailed a cancer screening kit by our lab.” (Doc. 12, ¶ 24). At some point Plaintiff was mailed a cancer screening kit,

which was provided by Elite Medical Laboratories, Inc. and Performance Laboratories, LLC. (Doc. 12, ¶ 25). With respect to Defendant Arriviello, Plaintiff alleges that the callers

referenced their “doctor” several times during the calls. Plaintiff alleges that the “doctor” the callers were referring to is Defendant Arriviello but does not explain how he knew that. He does, however, allege that Defendant Arriviello is “a medical doctor that provides consultation relating to cancer screening to the other

Defendants”—Elite Medical Laboratories, Inc. and Performance Laboratories, LLC. (Doc. 12, ¶ 1). He also alleges that Defendant Arriviello is “the prescribing doctor,” but does not allege what Defendant Arriviello prescribed or for whom.

(Doc. 12, ¶ 15). On May 31, 2019, Plaintiff filed this pro se civil Complaint in state court alleging violations of the TCPA, the regulations promulgated thereunder and

Trespass to Chattels against Elite Medical Laboratories, Inc., Performance Laboratories, LLC, and Richard Arriviello. (Doc. 1, ¶ 2). Defendant Arriviello paid the filing fee when this case was removed to federal court on June 6, 2019. (Doc.

1). Upon entering federal court, Defendant Arriviello filed his First Motion to Dismiss for Failure to State a Claim on June 26, 2019. (Doc. 26).2 On July 16, 2019 Plaintiff filed an Amended Complaint. (Doc. 12). In his Amended Complaint, Plaintiff alleges the following causes of action:

(1) Negligent Violation of the TCPA “ATDS” Prohibition, 47 U.S.C. § 227, (Doc. 12, p. 16); (2) Knowing and/or Willful Violation of the TCPA “ATDS” Prohibition, 47 U.S.C. § 227 et seq. (Doc. 12, p. 17); (3) Negligent Violation of TCPA “Sales Call/DNC” Prohibition, 47 U.S.C. § 227 et seq. (Doc. 12, p. 17); (4) Knowing and/or Willful violation of the TCPA “Sales Call/DNC” Prohibition, 47 U.S.C. § 227 et seq., (Doc. 12, p. 18); (5) Negligent Violation of the TCPA “Do-Not-Call Policy” Requirement, 47 C.F.R. 64.1200 et seq., (Doc 12, p. 18); (6) Knowing and/or Willful Violation of the TCPA “Do-Not-Call Policy” Requirement 47 C.F.R. 64.1200 et seq. (Doc. 12, pp. 18-19);

2 On August 14, 2019, Defendant Arriviello’s First Motion to Dismiss was dismissed as moot in light of the amended complaint. (Doc. 19).

(7) Negligent Violation of the TCPA “Do-Not-Call List” Requirement, 47 C.F.R. 64.1200 et seq. (Doc. 12, p. 19); (8) Knowing and/or Willful Violation of the TCPA “Do-Not-Call List” Requirement, 47 C.F.R. 64.1200 et seq. (Doc. 12, p. 19); (9) Trespass to chattels, (Doc. 12, p. 20). As relief, Plaintiff requests monetary compensation for each negligent violation of the TCPA, each knowing/willful violation of the TCPA, punitive damages, and compensation for trespass to chattels. (Doc. 12, ¶ 35).

On July 30, 2019, Defendant Arriviello filed his Second Motion to Dismiss for Failure to State a Claim. (Doc. 15). On August 12, 2019, Defendant Arriviello filed a Brief in Support. (Doc. 18). On August 28, 2019, Plaintiff filed his Brief in Opposition to the Second Motion to Dismiss for Failure to State a Claim. (Doc.

20). II. LEGAL STANDARD A motion to dismiss tests the legal sufficiency of a complaint. It is proper for

the court to dismiss a complaint in accordance with Rule 12(b)(6) of the Federal Rules of Civil Procedure only if the complaint fails to state a claim upon which relief can be granted. Fed. R. Civ. P. 12(b)(6). When reviewing a motion to dismiss, the court “must accept all factual allegations in the complaint as true,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Carnegie-Mellon University v. Cohill
484 U.S. 343 (Supreme Court, 1988)
Meyer v. Holley
537 U.S. 280 (Supreme Court, 2003)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Mayer v. Belichick
605 F.3d 223 (Third Circuit, 2010)
Santiago v. Warminster Township
629 F.3d 121 (Third Circuit, 2010)
Burtch v. Milberg Factors, Inc.
662 F.3d 212 (Third Circuit, 2011)
Morse v. Lower Merion School District
132 F.3d 902 (Third Circuit, 1997)
Sands v. McCormick
502 F.3d 263 (Third Circuit, 2007)
Phillips v. County of Allegheny
515 F.3d 224 (Third Circuit, 2008)
Fowler v. UPMC SHADYSIDE
578 F.3d 203 (Third Circuit, 2009)
Jose Gomez v. Campbell-Ewald Co.
768 F.3d 871 (Ninth Circuit, 2014)
Campbell-Ewald Co. v. Gomez
577 U.S. 153 (Supreme Court, 2016)
Richardson v. Verde Energy USA, Inc.
354 F. Supp. 3d 639 (E.D. Pennsylvania, 2018)
Duran v. La Boom Disco, Inc.
369 F. Supp. 3d 476 (E.D. New York, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
Kline v. Elite Medical Laboratories, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/kline-v-elite-medical-laboratories-inc-pamd-2019.